← Back to Search

Dual Artery Compression vs. Radial Artery-Only Hemostasis: Impact on Radial Artery Occlusion (EASY-RAO) (EASY-RAO Trial)

N/A
Waitlist Available
Research Sponsored by Olivier F. Bertrand
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* any patients referred for diagnostic angiography and possible percutaneous coronary intervention (PCI)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout intervention, up to 180 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to show that a dual artery compression device is better than a standard radial artery-only hemostasis device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout intervention, up to 180 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout intervention, up to 180 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of RAO after transradial approach (TRA) at hospital discharge
Secondary study objectives
Nursing involvement in hemostasis management for sensitivity analysis on cost assessment
Patient comfort during hemostasis as assessed on a visual scale
Percentage of radial artery patent-hemostasis during hemostasis
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dual Artery CompressionExperimental Treatment1 Intervention
time to hemostasis and incidence of radial artery occlusion will be monitored while using a dual artery compression device (Terry-2-band) to achieve hemostasis.
Group II: Radial Artery-OnlyActive Control1 Intervention
time to hemostasis and incidence of radial artery occlusion will be monitored while using the device currently approved by the institution (Hemo-Stop) and following institutional protocols for hemostasis.

Find a Location

Who is running the clinical trial?

Olivier F. BertrandLead Sponsor
2 Previous Clinical Trials
502 Total Patients Enrolled
~18 spots leftby Dec 2025